Aduhelm And The Power Of Doubt

 
• By Michael McCaughan

CMS is famous for not being able to negotiate prices – and its payment for physician-administered drugs notoriously incentivizes higher prices. Yet, as the Biogen/Eisai Aduhelm experience shows, CMS can on occasion have a profound impact on product launches when it chooses to.

Aduhelm - fear is the sales killer
Fear is the sales killer. • Source: Nielsen Hobbs; Pink Sheet | Alamy image

More from Medicare

More from Government Payers